GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Bought by First Trust Advisors LP

First Trust Advisors LP lifted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 22.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 568,569 shares of the company's stock after buying an additional 105,234 shares during the quarter. First Trust Advisors LP owned approximately 0.12% of GE HealthCare Technologies worth $44,451,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of GEHC. Epoch Investment Partners Inc. boosted its holdings in shares of GE HealthCare Technologies by 14.7% in the fourth quarter. Epoch Investment Partners Inc. now owns 651,838 shares of the company's stock valued at $50,961,000 after purchasing an additional 83,730 shares during the period. Forum Financial Management LP lifted its stake in GE HealthCare Technologies by 30.7% in the fourth quarter. Forum Financial Management LP now owns 7,953 shares of the company's stock worth $622,000 after acquiring an additional 1,869 shares during the period. Commerce Bank grew its holdings in GE HealthCare Technologies by 184.7% during the 4th quarter. Commerce Bank now owns 53,555 shares of the company's stock worth $4,187,000 after acquiring an additional 34,745 shares in the last quarter. Canada Pension Plan Investment Board increased its position in GE HealthCare Technologies by 4.8% during the 4th quarter. Canada Pension Plan Investment Board now owns 2,701,762 shares of the company's stock valued at $211,224,000 after purchasing an additional 124,651 shares during the period. Finally, Gratus Wealth Advisors LLC bought a new position in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $597,000. 82.06% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

GEHC has been the subject of a number of recent research reports. Citigroup boosted their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a report on Thursday, February 13th. BTIG Research set a $95.00 price target on shares of GE HealthCare Technologies and gave the company a "buy" rating in a research note on Monday, April 14th. Wells Fargo & Company upped their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research report on Friday, February 14th. The Goldman Sachs Group raised GE HealthCare Technologies from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $85.00 to $100.00 in a report on Tuesday, March 11th. Finally, Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their price objective for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, GE HealthCare Technologies has an average rating of "Moderate Buy" and an average target price of $96.50.

GE HealthCare Technologies Stock Down 0.8 %

Shares of NASDAQ GEHC traded down $0.55 during midday trading on Tuesday, hitting $67.52. 1,999,886 shares of the company's stock were exchanged, compared to its average volume of 3,262,665. The firm's fifty day simple moving average is $76.10 and its 200-day simple moving average is $81.91. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The company has a market cap of $30.91 billion, a PE ratio of 15.61, a P/E/G ratio of 3.19 and a beta of 1.14.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to analysts' expectations of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. Research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.21%. The ex-dividend date is Friday, April 25th. GE HealthCare Technologies's payout ratio is 3.23%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.